Skip to main content
BIO PROTECH INC. logo

BIO PROTECH INC. — Investor Relations & Filings

Ticker · 199290 ISIN · KR7199290008 LEI · 988400TYKP3J6SZOGR02 KO Manufacturing
Open in API
Filings indexed 281 across all filing types
Latest filing 2021-07-08 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 199290

About BIO PROTECH INC.

https://www.protechsite.com/

BIO PROTECH INC. is a manufacturer of medical equipment and disposable supplies. The company develops and produces a range of products for applications in surgery, cardiology, neurology, and pain management. Its portfolio includes electrosurgical devices such as smoke evacuators and surgical pencils, various electrocardiogram (ECG) electrodes, and transcutaneous electrical nerve stimulation (TENS) units. The company specializes in bio-medical sensors and related products developed using advanced skin technology for the global healthcare market.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a decision for a third-party allocation capital increase (유상증자결정). This is a formal regulatory filing submitted to the Financial Services Commission and Korea Exchange, detailing the issuance of new shares, the purpose of the capital raise, and the legal basis for the third-party allocation. This falls under the category of share issuance and capital changes.
2021-07-08 Korean
주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange, specifically detailing the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). This type of filing is a regulatory disclosure regarding capital structure changes and financing activities. In the provided taxonomy, 'CAP' (Capital/Financing Update) is the most accurate category for documents detailing the issuance of convertible bonds, as it directly relates to company financing and capital structure.
2021-07-08 Korean
기타시장안내(상장공시위원회 속개 안내)
Delisting Announcement Classification · 1% confidence The document is a short announcement from the exchange regarding the status of a company's listing (BioProtech). It specifically discusses the deliberation process for delisting and the continuation of a trading suspension. Since it is an official notice regarding the delisting process rather than the final delisting order itself, and it does not fit into other specific categories like M&A or financial reports, it is classified as a regulatory filing.
2021-05-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when a company insider (director or major shareholder) changes their shareholding position. This falls under the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives.
2021-05-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, specifically noting a third-party capital increase. This falls under the category of Major Shareholding Notification (MRQ) as it tracks significant ownership thresholds and changes.
2021-05-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service and Korea Exchange. This is a standard regulatory filing in South Korea used to disclose insider shareholdings and changes in ownership by directors and major shareholders. While it involves directors, it is specifically a disclosure of their share ownership status rather than a report of a personal trade (Director's Dealing) or a board change announcement. Given the specific nature of this regulatory disclosure regarding ownership status, it falls under the 'Director's Dealing' (DIRS) category as it reports the shareholding changes of an executive.
2021-05-07 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.